Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.78 - $57.04 $7.18 Million - $10 Million
176,000 Added 775.33%
198,700 $9.82 Million
Q2 2024

Aug 15, 2024

BUY
$50.42 - $64.29 $599,998 - $765,051
11,900 Added 110.19%
22,700 $1.37 Million
Q1 2024

May 07, 2024

SELL
$35.51 - $57.92 $63,918 - $104,256
-1,800 Reduced 14.29%
10,800 $557,000
Q4 2023

Feb 14, 2024

SELL
$20.91 - $40.9 $2.27 Million - $4.45 Million
-108,700 Reduced 89.61%
12,600 $508,000
Q3 2023

Nov 14, 2023

BUY
$27.05 - $33.37 $3.28 Million - $4.05 Million
121,300 New
121,300 $3.38 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.25B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.